Invests in publicly listed European healthcare companies active in specialty pharmaceuticals, medical technology, diagnostics, life science tools, specialized healthcare services, and selected healthcare platform companies. These businesses are characterized by clear strategic focus, strong positions in selected niches, and scalable business models. Competitive advantages, recurring revenue, disciplined capital allocation, and capital-efficient reinvestment support high-quality growth.
Updated 2026-03-23